McKesson price target raised by $80 at Jefferies, here's why

Wound and dermatology-focused Turn Therapeutics set to direct list on the Nasdaq today, 10/8

Cell and Gene Therapies on the Rise: New Report Reveals Growing Adoption and Persistent Challenges

Iterative Health Appoints Bill Kayser as President and Chief Financial Officer

Risk Management Analyst

McKesson is an impact-driven, Fortune 10 company that focuses on healthcare accessibility and affordability. The Risk Management Analyst will be responsible for resolving customer inquiries related to reimbursement issues, executing risk-mitigation holds, and managing financial obligations, while collaborating closely with various teams to ensure accuracy and compliance in processes.

Sign up with Google

Sign in with Google